Burkina Faso has recorded one of the most significant reductions in malaria burden in its history following an aggressive national strategy combining political leadership, mass deployment of advanced prevention tools, and the introduction of a new-generation vaccine.
According to official data released by Health Minister Robert Lucien Jean-Claude Kargougou and the African Leaders Malaria Alliance (ALMA), the country achieved sharp declines between 2024 and 2025 across key malaria indicators.
Sharp Decline in Cases and Deaths
Total malaria cases dropped from 10.8 million in 2024 to a projected 7.33 million in 2025, representing a 32% reduction.
Among children under five, cases fell from approximately 5 million to 3.1 million, a 38% decrease.
Malaria-related deaths declined from 3,523 in 2024 to 1,900 in 2025, marking a 48% reduction. Deaths among children under five decreased by 893 compared to the previous year.
Officials described the outcome as “historic,” attributing it to a coordinated three-pillar strategy.
Three Pillars Behind the Success
1. Rollout of the R21/Matrix-M Vaccine
Burkina Faso was among the first countries globally to introduce the R21/Matrix-M malaria vaccine into its routine immunization program.
By late 2025, high coverage of the four-dose regimen had been achieved nationwide. Modeling and early real-world data suggest that when combined with insecticide-treated bed nets, the vaccine reduces deaths among children under five by nearly 46%.
2. Mass Distribution of Advanced Bed Nets
The government distributed 15 million Long-Lasting Insecticidal Nets (LLINs) nationwide, prioritizing high-burden regions.
The new dual-active nets use next-generation insecticides to address mosquito resistance.
3. Strengthened Governance and Domestic Financing
Burkina Faso launched a national End Malaria Council and maintained health spending above 13% of the national budget, allocating an additional 5 billion XOF to vaccine expansion.
Gains Remain Fragile
WHO and ALMA warn that global malaria funding remains insufficient.
Nevertheless, Burkina Faso’s 2025 results represent one of the region’s most encouraging public health successes.
